Guía de práctica clínica 2021 para el diagnóstico, el tratamiento y el seguimiento de pacientes con espondiloartritis periférica. Asociación Colombiana de Reumatología
- 9 September 2021
- journal article
- practice guidelines
- Published by Elsevier BV in Revista Colombiana de Reumatología
- Vol. 29 (1), 44-56
- https://doi.org/10.1016/j.rcreu.2021.07.005
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- Clinical efficacy, radiographic and safety findings through 2 years of golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of the randomised, placebo-controlled GO-REVEAL studyAnnals Of The Rheumatic Diseases, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Efficacy in current practice of switching between anti-tumour necrosis factor- agents in spondyloarthropathiesRheumatology, 2010
- The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in generalAnnals Of The Rheumatic Diseases, 2010
- AGREE II: advancing guideline development, reporting and evaluation in health careCMAJ : Canadian Medical Association Journal, 2010
- Estimation of health care costs as a function of disease severity in people with psoriatic arthritis in the UKRheumatology, 2010
- The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapyRheumatology, 2008
- Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label studyAnnals Of The Rheumatic Diseases, 2008
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- Switching tumour necrosis factor antagonists in patients with ankylosing spondylitis and psoriatic arthritis: an observational study over a 5-year periodAnnals Of The Rheumatic Diseases, 2007